The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
1,026 Experimental treatments in acute stroke
Abstract
Objective: Preclinical evaluation of neuroprotectants fostered high expectations of clinical efficacy. When not matched, the question arises whether experiments are poor indicators of clinical outcome or whether the best drugs were not taken forward to clinical trial. Therefore, we endeavored to contrast experimental efficacy and scope of testing of drugs used clinically and those tested only experimentally. Methods: We identified neuroprotectants and reports of experimental efficacy via a systematic search. Controlled in vivo and in vitro experiments using functional or histological end points were selected for analysis. Relationships between outcome, drug mechanism, scope of testing, and clinical trial status were assessed statistically. Results: There was no evidence that drugs used clinically (114 drugs) were more effective experimentally than those tested only in animal models (912 drugs), for example, improvement in focal models averaged 31.3 ± 16.7% versus 24.4 ± 32.9%, p > 0.05, respectively. Scope of testing using Stroke Therapy Academic Industry Roundtable (STAIR) criteria was highly variable, and no relationship was found between mechanism and efficacy. Interpretation: The results question whether the most efficacious drugs are being selected for stroke clinical trials. This may partially explain the slow progress in developing treatments. Greater rigor in the conduct, reporting, and analysis of animal data will improve the transition of scientific advances from bench to bedside. Ann Neurol 2006
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias
Macleod, M. R., O’Collins, T., Howells, D. W., & Donnan, G. A. (2004) · Stroke · doi:10.1161/01.str.0000125719.25853.20 · Cited by 730
Self-citationGladstone, D. J., Black, S. E., & Hakim, A. M. (2002) · Stroke · doi:10.1161/01.str.0000025518.34157.51 · Cited by 635
Where is the evidence that animal research benefits humans?
Pound, P., Ebrahim, S., Sandercock, P., Bracken, M. B., & Roberts, I. (2004) · BMJ · doi:10.1136/bmj.328.7438.514 · Cited by 505
Multiple Molecular Penumbras after Focal Cerebral Ischemia
Sharp, F. R., Lu, A., Tang, Y., & Millhorn, D. E. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00001 · Cited by 403
Neuroprotection for ischemic stroke: Two decades of success and failure
Cheng, Y. D., Al-Khoury, L., & Zivin, J. A. (2004) · NeuroRX · doi:10.1602/neurorx.1.1.36 · Cited by 384
Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke
Macleod, M. R., O'Collins, T., Horky, L. L., Howells, D. W., & Donnan, G. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600064 · Cited by 176
Self-citationAnimal models of stroke: do they have value for discovering neuroprotective agents?
Richard Green, A., Odergren, T., & Ashwood, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00192-5 · Cited by 168
Hunter, A. J., Mackay, K. B., & Rogers, D. C. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01157-7 · Cited by 162
Research works printed but not linked: 3
- Cochrane Central Register of Controlled Trials (CENTRAL).2005.The Cochrane Collaboration John Wiley & Sons Ltd.
- Sharma SS, 2003, Emerging neuroprotective approaches in stroke treatment, Current Research & Information on Pharmaceutical Sciences, 4, 8
- Huang R, 1999, [Effects of defibrinogenase on photochemically induced middle cerebral artery occlusion in stroke‐prone renovascular hypertensive rats], Zhonghua Yi Xue Za Zhi, 79, 711
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Campbell, B. C. V., De Silva, D. A., Macleod, M. R., Coutts, S. B., Schwamm, L. H., Davis, S. M., & Donnan, G. A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0118-8 · Cited by 1,750
Self-citationCan Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Self-citationThe Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352
Self-citationNetwork pharmacology: curing causal mechanisms instead of treating symptoms
Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., & Schmidt, H. H. H. W. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.004 · Cited by 1,201
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Lakhan, S. E., Kirchgessner, A., & Hofer, M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-97 · Cited by 1,072
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Paul, S., & Candelario-Jalil, E. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113518 · Cited by 748
NXY-059 for the Treatment of Acute Ischemic Stroke
Shuaib, A., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Diener, H.-C., Ashwood, T., Wasiewski, W. W., & Emeribe, U. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070240 · Cited by 732
Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., et al. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/627375 · Cited by 687
Animal models of ischemic stroke and their application in clinical research
Kleinschnitz, C., Fluri, F., & Schuhmann, M. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s56071 · Cited by 650
Animal models of human disease: challenges in enabling translation
McGonigle, P., & Ruggeri, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.006 · Cited by 610
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.564872 · Cited by 605
Molecular pathophysiology of cerebral edema
Stokum, J. A., Gerzanich, V., & Simard, J. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15617172 · Cited by 587
Loane, D. J., & Faden, A. I. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.005 · Cited by 574
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
The Flaws and Human Harms of Animal Experimentation
AKHTAR, A. (2015) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180115000079 · Cited by 527
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis
van der Worp, H. B., Sena, E. S., Donnan, G. A., Howells, D. W., & Macleod, M. R. (2007) · Brain · doi:10.1093/brain/awm083 · Cited by 498
Self-citationMeta-analysis of data from animal studies: A practical guide
Vesterinen, H. M., Sena, E. S., Egan, K. J., Hirst, T. C., Churolov, L., Currie, G. L., Antonic, A., Howells, D. W., & Macleod, M. R. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.09.010 · Cited by 488
Self-citationAdibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447
Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain
Cook, D. J., Teves, L., & Tymianski, M. (2012) · Nature · doi:10.1038/nature10841 · Cited by 443
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
Hwang, T. J., Carpenter, D., Lauffenburger, J. C., Wang, B., Franklin, J. M., & Kesselheim, A. S. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6008 · Cited by 442
Pound, P., & Ritskes-Hoitinga, M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1678-1 · Cited by 419
Pathophysiologic Cascades in Ischemic Stroke
Xing, C., Arai, K., Lo, E. H., & Hommel, M. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00839.x · Cited by 416
Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
Saver, J. L., Starkman, S., Eckstein, M., Stratton, S. J., Pratt, F. D., Hamilton, S., Conwit, R., Liebeskind, D. S., Sung, G., Kramer, I., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408827 · Cited by 407
Hill, M. D., Martin, R. H., Mikulis, D., Wong, J. H., Silver, F. L., terBrugge, K. G., Milot, G., Clark, W. M., MacDonald, R. L., Kelly, M. E., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70225-9 · Cited by 400
van der Worp, H. B., & van Gijn, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp072057 · Cited by 399
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Golde, T. E., Schneider, L. S., & Koo, E. H. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.002 · Cited by 382
Immune interventions in stroke
Fu, Y., Liu, Q., Anrather, J., & Shi, F.-D. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.144 · Cited by 383
How can we improve the pre-clinical development of drugs for stroke?
Sena, E., van der Worp, H. B., Howells, D., & Macleod, M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.009 · Cited by 365
Self-citationBrain temperature and its fundamental properties: a review for clinical neuroscientists
Wang, H., Wang, B., Normoyle, K. P., Jackson, K., Spitler, K., Sharrock, M. F., Miller, C. M., Best, C., Llano, D., & Du, R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00307 · Cited by 356
Bench to Bedside: The Quest for Quality in Experimental Stroke Research
Dirnagl, U. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600298 · Cited by 349
Hemmen, T. M., Raman, R., Guluma, K. Z., Meyer, B. C., Gomes, J. A., Cruz-Flores, S., Wijman, C. A., Rapp, K. S., Grotta, J. C., & Lyden, P. D. (2010) · Stroke · doi:10.1161/strokeaha.110.592295 · Cited by 341
Brines, M., & Cerami, A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02024.x · Cited by 333
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems
Pushie, M. J., Pickering, I. J., Korbas, M., Hackett, M. J., & George, G. N. (2014) · Chemical Reviews · doi:10.1021/cr4007297 · Cited by 332
Müller cells and diabetic retinopathy
Coughlin, B. A., Feenstra, D. J., & Mohr, S. (2017) · Vision Research · doi:10.1016/j.visres.2017.03.013 · Cited by 332
Good Laboratory Practice: Preventing Introduction of Bias at the Bench
Macleod, M. R., Fisher, M., O'Collins, V., Sena, E. S., Dirnagl, U., Bath, P. M. W., Buchan, A., van der Worp, H. B., Traystman, R., Minematsu, K., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.525386 · Cited by 331
Self-citationSystemic infection, inflammation and acute ischemic stroke
McColl, B. W., Allan, S. M., & Rothwell, N. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.019 · Cited by 318
Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke
Campbell, B. C. V., Donnan, G. A., Lees, K. R., Hacke, W., Khatri, P., Hill, M. D., Goyal, M., Mitchell, P. J., Saver, J. L., Diener, H.-C., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00140-4 · Cited by 313
Self-citationAnimal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
Kwon, B. K., Stammers, A. M. T., Belanger, L. M., Bernardo, A., Chan, D., Bishop, C. M., Slobogean, G. P., Zhang, H., Umedaly, H., Giffin, M., et al. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1080 · Cited by 310
Howells, D. W., Porritt, M. J., Rewell, S. S., O'Collins, V., Sena, E. S., van der Worp, H. B., Traystman, R. J., & Macleod, M. R. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.66 · Cited by 309
Self-citationHenderson, V. C., Kimmelman, J., Fergusson, D., Grimshaw, J. M., & Hackam, D. G. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001489 · Cited by 302
Evaluation of excess significance bias in animal studies of neurological diseases
Tsilidis, K. K., Panagiotou, O. A., Sena, E. S., Aretouli, E., Evangelou, E., Howells, D. W., Salman, R. A.-S., Macleod, M. R., & Ioannidis, J. P. A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001609 · Cited by 295
Self-citationIschemic stroke in the elderly: an overview of evidence
Chen, R.-L., Balami, J. S., Esiri, M. M., Chen, L.-K., & Buchan, A. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.36 · Cited by 291
Zhu, T., Wang, L., Wang, L.-P., & Wan, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112719 · Cited by 287
Encouraging an excitable brain state: mechanisms of brain repair in stroke
Joy, M. T., & Carmichael, S. T. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00396-7 · Cited by 285
Oxidative Stress and the Use of Antioxidants in Stroke
Shirley, R., Ord, E., & Work, L. (2014) · Antioxidants · doi:10.3390/antiox3030472 · Cited by 282
Macrae, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01398.x · Cited by 274
Neumann, J., Riek-Burchardt, M., Herz, J., Doeppner, T. R., König, R., Hütten, H., Etemire, E., Männ, L., Klingberg, A., Fischer, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1355-2 · Cited by 274
Chen, R., Lai, U. H., Zhu, L., Singh, A., Ahmed, M., & Forsyth, N. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00132 · Cited by 269
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity
Weilinger, N. L., Lohman, A. W., Rakai, B. D., Ma, E. M. M., Bialecki, J., Maslieieva, V., Rilea, T., Bandet, M. V., Ikuta, N. T., Scott, L., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4236 · Cited by 266
Sena, E. S., Currie, G. L., McCann, S. K., Macleod, M. R., & Howells, D. W. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.28 · Cited by 264
Self-citationNeuroprotection for Ischaemic Stroke: Translation from the Bench to the Bedside
Sutherland, B. A., Minnerup, J., Balami, J. S., Arba, F., Buchan, A. M., & Kleinschnitz, C. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00770.x · Cited by 259
Stroke, Vascular Dementia, and Alzheimer’s Disease: Molecular Links
Vijayan, M., & Reddy, P. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160527 · Cited by 261
Improving Outcome after Stroke: Overcoming the Translational Roadblock
Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., Planas, A., Rothwell, N., Schwaninger, M., Schwab, M. E., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000118039 · Cited by 258
NXY-059 for the Treatment of Acute Stroke: Pooled Analysis of the SAINT I and II Trials
Diener, H.-C., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Shuaib, A., Ashwood, T., Wasiewski, W., Alderfer, V., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.503334 · Cited by 255
Llovera, G., Hofmann, K., Roth, S., Salas-Pérdomo, A., Ferrer-Ferrer, M., Perego, C., Zanier, E. R., Mamrak, U., Rex, A., Party, H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9853 · Cited by 253
Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy
Papadakis, M., Hadley, G., Xilouri, M., Hoyte, L. C., Nagel, S., McMenamin, M. M., Tsaknakis, G., Watt, S. M., Drakesmith, C. W., Chen, R., et al. (2013) · Nature Medicine · doi:10.1038/nm.3097 · Cited by 232
Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke
Vu, Q., Xie, K., Eckert, M., Zhao, W., & Cramer, S. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000278 · Cited by 235
Azzopardi, D., Robertson, N. J., Bainbridge, A., Cady, E., Charles-Edwards, G., Deierl, A., Fagiolo, G., Franks, N. P., Griffiths, J., Hajnal, J., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00347-6 · Cited by 220
Systematic reviews of animal models: methodology versus epistemology
Greek, R., & Menache, A. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5529 · Cited by 207
de Vries, R. B. M., Wever, K. E., Avey, M. T., Stephens, M. L., Sena, E. S., & Leenaars, M. (2014) · ILAR Journal · doi:10.1093/ilar/ilu043 · Cited by 165
Translating animal research into clinical benefit
Hackam, D. G. (2007) · BMJ · doi:10.1136/bmj.39104.362951.80 · Cited by 157
More than 3Rs: The importance of scientific validity for harm-benefit analysis of animal research
Würbel, H. (2017) · Lab Animal · doi:10.1038/laban.1220 · Cited by 152
ElAli, A., Doeppner, T. R., Zechariah, A., & Hermann, D. M. (2011) · Stroke · doi:10.1161/strokeaha.111.615559 · Cited by 150
Kilic, E., Kilic, Ü., Bacigaluppi, M., Guo, Z., Abdallah, N. B., Wolfer, D. P., Reiter, R. J., Hermann, D. M., & Bassetti, C. L. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00568.x · Cited by 140
Ramirez, F. D., Motazedian, P., Jung, R. G., Di Santo, P., MacDonald, Z. D., Moreland, R., Simard, T., Clancy, A. A., Russo, J. J., Welch, V. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310628 · Cited by 138
Bringing rigour to translational medicine
Howells, D. W., Sena, E. S., & Macleod, M. R. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.232 · Cited by 130
Self-citationEvolution and Translation of Research Findings: From Bench to Where
Ioannidis, J. P. A. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010036 · Cited by 129
Cytoprotective protein C pathways and implications for stroke and neurological disorders
Zlokovic, B. V., & Griffin, J. H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.005 · Cited by 128
Decoding the Transcriptional Response to Ischemic Stroke in Young and Aged Mouse Brain
Androvic, P., Kirdajova, D., Tureckova, J., Zucha, D., Rohlova, E., Abaffy, P., Kriska, J., Valny, M., Anderova, M., Kubista, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107777 · Cited by 118
Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility
Knight, A. (2007) · Alternatives to Laboratory Animals · doi:10.1177/026119290703500610 · Cited by 105
Experimental models of multiple sclerosis
Pachner, A. R. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346c226 · Cited by 90
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Golde, T. E., Petrucelli, L., & Lewis, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.035 · Cited by 89
“was often only performed after a failure in the clinic (often in an attempt to explain that failure; O'Collins et al., 2006).”
Role of Nogo-A in neuronal survival in the reperfused ischemic brain
Kilic, E., ElAli, A., Kilic, Ü., Guo, Z., Ugur, M., Uslu, U., Bassetti, C. L., Schwab, M. E., & Hermann, D. M. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.268 · Cited by 79
Burns, T. C., Li, M. D., Mehta, S., Awad, A. J., & Morgan, A. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.021 · Cited by 79
Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results
Lyden, P. D., Bosetti, F., Diniz, M. A., Rogatko, A., Koenig, J. I., Lamb, J., Nagarkatti, K. A., Cabeen, R. P., Hess, D. C., Kamat, P. K., et al. (2022) · Stroke · doi:10.1161/strokeaha.121.038047 · Cited by 73
The researchers’ view of scientific rigor—survey on the conduct and reporting of in vivo research
Reichlin, T. S., Vogt, L., & Würbel, H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165999 · Cited by 72
Thomas Willis Lecture: Is Translational Stroke Research Broken, and if So, How Can We Fix It?
Dirnagl, U. (2016) · Stroke · doi:10.1161/strokeaha.116.013244 · Cited by 61
Insulin, Synaptic Function, and Opportunities for Neuroprotection
Mielke, J. G., & Wang, Y.-T. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385506-0.00004-1 · Cited by 55
Härtig, W., Mages, B., Aleithe, S., Nitzsche, B., Altmann, S., Barthel, H., Krueger, M., & Michalski, D. (2017) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2017.00015 · Cited by 53
Maskery, M. P., Holscher, C., Jones, S. P., Price, C. I., Strain, W. D., Watkins, C. L., Werring, D. J., & Emsley, H. C. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20952011 · Cited by 51
Reporting standards for preclinical studies of stroke therapy
Vahidy, F., Schäbitz, W.-R., Fisher, M., & Aronowski, J. (2016) · Stroke · doi:10.1161/strokeaha.116.013643 · Cited by 39
Giuliani, D., Ottani, A., Neri, L., Zaffe, D., Grieco, P., Jochem, J., Cavallini, G. M., Catania, A., & Guarini, S. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.004 · Cited by 38
The neuroprotective mechanism of lithium after ischaemic stroke
Chen, B., Zhang, M., Ji, M., Zhang, D., Chen, B., Gong, W., Li, X., Zhou, Y., Dong, C., Wen, G., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03051-2 · Cited by 37
Krauth, D., Anglemyer, A., Philipps, R., & Bero, L. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001770 · Cited by 36
Enhancing reproducibility: Failures from Reproducibility Initiatives underline core challenges
Mullane, K., & Williams, M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.008 · Cited by 28
How our approaches to assessing benefits and harms can be improved
Sena, E., & Currie, G. (2019) · Animal Welfare · doi:10.7120/09627286.28.1.107 · Cited by 23
Michalski, D., Pitsch, R., Pillai, D. R., Mages, B., Aleithe, S., Grosche, J., Martens, H., Schlachetzki, F., & Härtig, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174996 · Cited by 15
Lee, H. K., Kwon, D. H., Aylor, D. L., & Marchuk, D. A. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.09.003 · Cited by 6
Metadata
- Authors
- O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2006-02-17
- Volume
- 59
- Issue
- 3
- Pages
- 467-477
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2157368934
- Cited by
- 1,460
- References
- 22
- FWCI
- 36.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.